retatrutide glp-1 Retatrutide: Comprehensive Safety and Clinical Data Retatrutide, an experimental weight-loss drug,

4-6 Only three GLP-1 medications are currently FDA approved for weight loss: liraglutide (Saxenda), semaglutide (Wegovy) and tirzepatide (Zepbound)

It is important to note that Ozempic is not used to treat type 1 diabetes, and is not the same as insulin

Please note that because GSK is unable to control the quality of our products sold by unauthorized sellers, the Guarantee is not available for products purchased from unauthorized sellers due to potential quality issues outside GSKs control

However, the BALANCE Model, a CMS Innovation Center payment and service delivery model adopted under Section 1115A of the Social Security Act, is designed to fill this gap and provide eligible Medicare and Medicaid beneficiaries with coverage of these drugs for weight loss purposes

, Golani, O

95% CI, 0.87 to 1.52) [33]